Besides, Smad3 inhibition in uremic-PD rat models treated with recombinant BMP7 decreased peritoneal fibrosis, sub-mesothelial capillary density, and increased UF capacity [80,81]. The gene discussed is BMP7; the disease is Peritoneal Fibrosis.